$Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas$

Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas

In patients with adenocarcinoma of the pancreas, there are no standard second-line regimens. Many pre-clinical studies have shown that metformin alone or when combined with paclitaxel has antitumour effects on this tumour. We have tested here the combination of paclitaxel and metformin for patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ecancermedicalscience 2015-08, Vol.9, p.563-563
Hauptverfasser:	Braghiroli, Maria Ignez, de Celis Ferrari, Anezka C R, Pfiffer, Tulio Eduardo, Alex, Alexandra Kichfy, Nebuloni, Daniela, Carneiro, Allyne S, Caparelli, Fernanda, Senna, Luiz, Lobo, Juliana, Hoff, Paulo Marcelo, Riechelmann, Rachel P
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Study
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!